Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $5.31B | -$372M | 78 | 0.13% | Reduced |
|
| 2 |
BlackRock
New York
| $5.24B | -$362M | 85 | 0.15% | Reduced |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $3.07B | -$72.7M | 61 | 0.27% | Reduced |
|
| 4 |
State Street
Boston,
Massachusetts
| $2.36B | -$213M | 78 | 0.13% | Reduced |
|
| 5 |
Janus Henderson Group
London,
| $1.99B | +$43.2M | 28 | 1.3% | Increased |
|
| 6 |
T. Rowe Price Associates
Baltimore,
Maryland
| $1.87B | -$11.2M | 41 | 0.27% | Reduced |
|
| 7 |
Wellington Management Group
Boston,
Massachusetts
| $1.83B | +$173M | 20 | 0.37% | Increased |
|
| 8 |
Dodge & Cox
San Francisco,
California
| $1.66B | -$14.5M | 1 | 1.12% | Reduced |
|
| 9 |
Primecap Management
Pasadena,
California
| $1.6B | -$36.7M | 5 | 1.35% | Reduced |
|
| 10 |
Morgan Stanley
New York
| $1.51B | -$55.4M | 88 | 0.15% | Reduced |
|
| 11 |
Geode Capital Management
Boston,
Massachusetts
| $1.13B | +$50.3M | 90 | 0.13% | Increased |
|
| 12 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $1.11B | +$266M | 8 | 0.79% | Increased |
|
| 13 |
Dimensional Fund Advisors
Austin,
Texas
| $1.06B | -$12.8M | 47 | 0.35% | Reduced |
|
| 14 |
JP Morgan Chase
New York
| $1.04B | +$3.42M | 79 | 0.11% | Increased |
|
| 15 |
Franklin Resources
San Mateo,
California
| $1.03B | -$36M | 31 | 0.52% | Reduced |
|
| 16 |
Capital World Investors
Los Angeles,
California
| $990M | +$94.5M | 5 | 0.2% | Increased |
|
| 17 |
Bank of America
Charlotte,
North Carolina
| $974M | -$14.5M | 77 | 0.11% | Reduced |
|
| 18 |
RTW Investments
New York
| $897M | +$31.6M | 7 | 18.92% | Increased |
|
| 19 |
Avoro Capital Advisors
New York
| $877M | -$324M | 5 | 13.68% | Reduced |
|
| 20 |
Charles Schwab
San Francisco,
California
| $853M | -$9.83M | 50 | 0.24% | Reduced |
|
| 21 |
Kohlberg Kravis Roberts & Co
New York
| $819M | $0 | 1 | 28.75% | Maintained |
|
| 22 |
Goldman Sachs
New York
| $762M | -$228M | 56 | 0.16% | Reduced |
|
| 23 |
Capital International Investors
Los Angeles,
California
| $760M | +$184M | 6 | 0.19% | Increased |
|
| 24 |
Viking Global Investors
Stamford,
Connecticut
| $723M | -$42.6M | 2 | 2.94% | Reduced |
|
| 25 |
Northern Trust
Chicago,
Illinois
| $709M | -$34M | 75 | 0.14% | Reduced |
|